Clinical staging: A heuristic and practical strategy for new research and better health and social outcomes for psychotic and related mood disorders

Canadian Journal of Psychiatry

Volumn 55, Issue 8, 2010, Pages 486-497

  McGorry, Patrick D ^a   Nelson, Barnaby ^a   Goldstone, Sherilyn ^a   Yung, Alison R ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Adolescents; Bipolar disorder; Clinical staging; Early intervention; Mood disorder; Pluripotential risk syndrome; Psychosis; Psychosis prodrome; Schizophrenia; Youth mental health

Indexed keywords

CLINICAL FEATURE; DISEASE CLASSIFICATION; DISEASE COURSE; MENTAL DISEASE; MOOD DISORDER; PSYCHOSIS; REVIEW;

EID: 77956912628     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674371005500803     Document Type: Review

References (112)

1. Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:593-602. (Pubitemid 40973434)
2. Arnett JJ. Emerging adulthood. The winding road from the late teens through the twenties. New York (NY): Oxford University Press; 2004.
3. Eckersley RM. Never better - or getting worse? The health and wellbeing of young Australians. Australia21;2008.
4. Paus T, Keshavan M, Giedd JN. Why do many psychiatric disorders emerge during adolescence? Nature Rev. 2008;9:947-957.
5. Stice E, Burton E, Bearman SK, et al. Randomized trial of a brief depression prevention program: an elusive search for a psychosocial placebo control condition. Behav Res Ther. 2007;45:863-876.
6. Eaton WW, Badawi M, Melton B. Prodromes and precursors: epidemiologic data for primary prevention of disorders with slow onset. Am J Psychiatry. 1995;152:967-972.
7. Sullivan HS. The onset of schizophrenia. Am J Psychiatry. 1927;6:105-134.
8. Harrington R, Clark A. Prevention and early intervention for depression in adolescence and early adult life. Eur Arch Psychiatry Clin Neurosci. 1998;248:32-45.
9. Hetrick S, Simmons M, Merry S. SSRIs and depression in children and adolescents: the imperative for shared decision-making. Australas Psychiatry. 2008;16:354-358.
10. Seeley JR, Stice E, Rohde P. Screening for depression prevention: identifying adolescent girls at high risk for future depression. J Abnorm Psychol. 2009;118:161-170.
11. Yung AR, Phillips LJ, Yuen HP, et al. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr Res. 2004;67:131-142.
12. Regier DA, Narrow WE, Kuhl EA, et al. The conceptual development of DSM-V. Am J Psychiatry. 2009;166:645-650.
13. Jansson LB, Parnas J. Competing definitions of schizophrenia: what can be learned from polydiagnostic studies? Schizophr Bull. 2007;33:1178-1200.
14. McGorry PD, Hickie IB, Yung AR, et al. Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust N Z J Psychiatry. 2006;40:616-622.
15. McGorry PD, Purcell R, Hickie IB, et al. Clinical staging: a heuristic model for psychiatry and youth mental health. Med J Aust. 2007;187:S40-S42.
16. Insel TR. The arrival of preemptive psychiatry. Early Interv Psychiatry. 2007;1:5-6.
17. Edwards J, McGorry P. Implementing early intervention in psychosis: a guide to establishing early psychosis services. London (GB): Martin Dunitz; 2002.
18. McGlashan TH. Early detection and intervention of schizophrenia: rationale and research. Br J Psychiatry. 1998;172(33):3-6.
19. McGorry PD, Edwards J, Mihalopoulos C, et al. EPPIC: an evolving system of early detection and optimal management. Schizophr Bull. 1996;22(2):305-326.
20. McGorry PD, Yung AR. Early intervention in psychosis: an overdue reform. Aust N Z J Psychiatry. 2003;37(4):393-398.
21. Harrigan SM, McGorry PD, Krstev H. Does treatment delay in first-episode psychosis really matter? Psychol Med. 2003;33:97-110.
22. Marshall M, Lewis S, Lockwood A, et al. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry. 2005;62:975-983.
23. Perkins DO, Gu H, Boteva K, et al. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am J Psychiatry. 2005;162:1785-1804.
24. Keshavan MS, Amirsadri A. Early intervention in schizophrenia: current and future perspectives. Curr Psychiatry Rep. 2007;9:325-328.
25. Johannessen JO, McGlashan TH, Larsen TK, et al. Early detection strategies for untreated first-episode psychosis. Schizophr Res. 2001;51:39-46.
26. Johannessen JO, Larsen TK, Joa I, et al. Pathways to care for first-episode psychosis in an early detection healthcare sector: part of the Scandinavian TIPS study. Br J Psychiatry. 2005;48:s24-s28.
27. Larsen TK, Friis S, Haahr U, et al. Early detection and intervention in first-episode schizophrenia: a critical review. Acta Psychiatr Scand. 2001;103:323-334.
28. Larsen TK, Melle I, Auestad B, et al. Early detection of first-episode psychosis: the effect on 1-year outcome. Schizophr Bull. 2006;32:758-764.
29. Lieberman JA, Tollefson GD, Charles C, et al. Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry. 2005;62:361-370.
30. Hafner H, Maurer K, Loffler W, et al. The influence of age and sex on the onset and early course of schizophrenia. Br J Psychiatry. 1993;162:80-86.
31. Yung AR, McGorry PD. The initial prodrome in psychosis: descriptive and qualitative aspects. Aust N Z J Psychiatry. 1996;30:587-599.
32. Hafner H, Maurer K, Loffler W, et al. Modeling the early course of schizophrenia. Schizophr Bull. 2003;29:325-340.
33. Huber G, Gross G, Schüttler R. Schizophrenie. Verlaufs- und sozialpsychiatrische Langzeituntersuchungen an den 1945 bis 1959 in Bonn hospitalisierten schizophrenen Kranken. Berlin (DE): Springer-Verlag; 1979.
34. Yung AR. The schizophrenia prodrome: a high-risk concept. Schizophr Bull. 2003;29:859-865.
35. McGorry PD, Phillips LJ, Yung AR. Recognition and treatment of the pre-psychotic phase of the psychotic disorders: frontier or fantasy? In: Miller T, Mednick S, McGlashan T, et al, editors. Early intervention in psychiatric disorders. Amsterdam (DK): Kluwer; 2001. p 101-122.
36. Yung AR, Phillips LJ, McGorry PD, et al. Prediction of psychosis. A step towards indicated prevention of schizophrenia. Br J Psychiatry. 1998;172:14-20.
37. Yung AR, Phillips LJ, McGorry PD. Treating schizophrenia in the prodromal phase. London (GB): Taylor and Francis; 2004.
38. Yung AR, Phillips LJ, Yuen HP, et al. Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group. Schizophr Res. 2003;60:21-32.
39. Mason O, Startup M, Halpin S, et al. Risk factors for transition to first episode psychosis among individuals with 'at-risk mental states'. Schizophr Res. 2004;71:227-237.
40. Miller TJ, McGlashan TH, Rosen JL, et al. Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity. Am J Psychiatry. 2002;159:863-865.
41. Riecher-Rössler A, Gschwandtner U, Aston J, et al. The Basel early-detection-of-psychosis (FEPSY)-study - design and preliminary results. Acta Psychiatr Scand. 2007;115:114-125.
42. Addington J, Cadenhead KS, Cannon TD, et al. North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research. Schizophr Bull. 2007;33:665-672.
43. Cannon TD, Cadenhead K, Cornblatt B, et al. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry. 2008;65:28-37.
44. Ruhrmann S, Schultze-Lutter F, Klosterkotter J. Early detection and intervention in the initial prodromal phase of schizophrenia. Pharmacopsychiatry. 2003;36:S162-S167.
45. McGorry PD, Nelson B, Amminger GP, et al. Intervention in individuals at ultra high risk for psychosis: a review and future directions. J Clin Psychiatry. 2009;70(9):1206-1212.
46. McGorry PD, Yung AR, Phillips LJ, et al. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry. 2002;59:921-928.
47. Phillips LJ, McGorry PD, Yuen HP, et al. Medium term follow-up of a randomized controlled trial of interventions for young people at ultra high risk of psychosis. Schizophr Res. 2007;96:25-33.
48. McGlashan T, Zipursky R, Perkins D, et al. Olanzapine for the treatment of schizophrenia prodrome: 2 year results of a randomized placebo controlled trial. World J Biol Psychiatry. 2004;5:146.
49. McGlashan TH, Zipursky RB, Perkins D, et al. Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry. 2006;163:790-799.
50. Morrison AP, French P, Walford L, et al. Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial. Br J Psychiatry. 2004;185:291-297.
51. Bechdolf A, Wagner M, Klosterkotter J. Cognitive behaviour therapy (CBT) in the early initial prodromal state of psychosis: concept and practical approach. Schizophr Res. 2006;86:S96.
52. Nordentoft M, Thorup A, Petersen L, et al. Transition rates from schizotypal disorder to psychotic disorder for first-contact patients included in the OPUS trial. A randomized clinical trial of integrated treatment and standard treatment. Schizophr Res. 2006;83:29-40.
53. Cornblatt BA, Lencz T, Smith CW, et al. Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents. J Clin Psychiatry. 2007;68:546-557.
54. Fusar-Poli P, Valmaggia L, McGuire P. Can antidepressants prevent psychosis? Lancet. 2007;370:1746-1748.
55. Woods SW, Tully EM, Walsh BC, et al. Aripiprazole in the treatment of the psychosis prodrome: an open-label pilot study. Br J Psychiatry. 2007;51:s96-s101.
56. Woods SW, Walsh BC, Pearlson GD, et al. Glycine treatment of prodromal symptoms. Schizophr Res. 2006;86:s7-s17.
57. Phillips L, Nelson B, Yuen HP, et al. Randomized controlled trial of interventions for young people at UHR of psychosis: study design and baseline characteristics. Aust N Z J Psychiatry. 2009 ;43(9):818-829.
58. McGorry P, Phillips L, Nelson B, et al. A double-blind, placebo controlled randomized trial of low-dose risperidone, cognitive-behavioural therapy, and befriending in young people with subthreshold symptoms at incipient risk of psychotic disorder: six month outcome data. Schizophr Bull. 2007;33(2):446.
59. Yung AR, Yuen HP, Berger G, et al. Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk? Schizophr Bull. 2007;33:673-681.
60. Laurens KR, Hodgins S, Maughan B, et al. Community screening for psychotic-like experiences and other putative antecedents of schizophrenia in children aged 9-12 years. Schizophr Res. 2007;90:130-146.
61. Yung AR, Buckby JA, Cosgrave EM, et al. Association between psychotic experiences and depression in a clinical sample over 6 months. Schizophr Res. 2007;91:246-253.
62. Amminger GP, Schäfer MR, Papageorgiou K, et al. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo controlled trial. Arch Gen Psychiatry. 2010;67(2):146-154.
63. Berger GE, Proffitt TM, McConchie M, et al. Ethyl-eicosapentaenoic acid in first-episode psychosis: a randomized, placebo-controlled trial. J Clin Psychiatry. 2007;68:1867-1875.
64. Emsley R, Myburgh C, Oosthuizen P, et al. Randomized, placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia. Am J Psychiatry. 2002;159:1596-1598.
65. Fenton WS, Dickerson F, Boronow J, et al. A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia. Am J Psychiatry. 2001;158:2071-2074.
66. Freeman MP, Hibbeln JR, Wisner KL, et al. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry. 2006;67:1954-1967.
67. Peet M, Stokes C. Omega-3 fatty acids in the treatment of psychiatric disorders. Drugs. 2005;65:1051-1059.
68. Kahn RS, Fleischhacker WW, Boter H, et al. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet. 2008;371:1085-1097.
69. McGlashan TH. Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course? Biol Psychiatry. 1999;46:899-907.
70. Melle I, Larsen TK, Friis S, et al. Early detection of first psychosis: TIPS sample five-year outcomes. Schizophr Bull. 2009;35:330.
71. Bottlender R, Sato T, Jager M, et al. The impact of duration of untreated psychosis and premorbid functioning on outcome of first inpatient treatment in schizophrenic and schizoaffective patients. Eur Arch Psychiatry Clin Neurosci. 2002;252:226-231.
72. Harris MG, Henry LP, Harrigan SM, et al. The relationship between duration of untreated psychosis and outcome: an eight-year prospective study. Schizophr Res. 2005;79:85-93.
73. Farooq S, Large M, Nielssen O. Early intervention in psychosis in developing countries: evidence and action. World Psychiatry. 2009;8:123.
74. International Early Psychosis Association Writing Group. International clinical practice guidelines for early psychosis. Br J Psychiatry. 2005;187:s120-s124.
75. Parsons B, Allison DB, Loebel A, et al. Weight effects associated with antipsychotics: a comprehensive database analysis. Schizophr Res. 2009;110:103-110.
76. Jackson HJ, McGorry PD, Killackey E, et al. Acute-phase and 1-year follow-up results of a randomized controlled trial of CBT versus Befriending for first-episode psychosis: the ACE project. Psychol Med. 2008;38:725-735.
77. Fowler D, Hodgekins J, Painter M, et al. Cognitive behaviour therapy for improving social recovery in psychosis: a report from the ISREP MRC Trial Platform Study (Improving Social Recovery in Early Psychosis). Psychol Med. 2009;39(10):1627-1636.
78. Fraser R, Berger G, Killackey E, et al. Emerging psychosis in young people - Part 3 - key issues for prolonged recovery. Aust Fam Physician. 2006;35:329-333.
79. Killackey EJ, Jackson HJ, Gleeson J, et al. Exciting career opportunity beckons! Early intervention and vocational rehabilitation in first-episode psychosis: employing cautious optimism. Aust N Z J Psychiatry. 2006;40:951-962.
80. Killackey E, Jackson HJ, McGorry PD. Vocational intervention in first-episode psychosis: individual placement and support v treatment as usual. Br J Psychiatry. 2008;193:114-120.
81. Eack SM, Greenwald DP, Hogarty SS, et al. Cognitive enhancement therapy for early-course schizophrenia: effects of a two-year randomized controlled trial. Psychiatr Serv. 2009;60(11):1468-1476.
82. Wykes T, Newton E, Landau S, et al. Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial. Schizophr Res. 2007;94:221-230.
83. Berger G, Dell'Olio M, Amminger GP, et al. Neuroprotection in emerging psychotic disorders. Early Interv Psychiatry. 2007;1:114-127.
84. Berk M, Copolov D, Dean O, et al. N-acetyl cysteine as a glutathione precursor for schizophrenia - a double-blind, randomized, placebo-controlled trial. Biol Psychiatry. 2008;64:361-368.
85. Killackey E, McGorry P. Interventions in the early stages of psychosis. Psychiatr Ann. 2008;88:521-527.
86. McGorry PD, Yung AR, Bechdolf A, et al. Back to the future: predicting and reshaping the course of psychotic disorder. Arch Gen Psychiatry. 2008;65:25-27.
87. Mihalopoulos C, Harris M, Henry L, et al. Is early intervention in psychosis cost-effective over the long term? Schizophr Bull. 2009;35(5):909-918.
88. Yung AR, McGorry PD, Francey SM, et al. PACE: a specialised service for young people at risk of psychotic disorders. Med J Aust. 2007;187:S43-S46.
89. Lenior ME, Dingemans PM, Linszen DH, et al. Social functioning and the course of early-onset schizophrenia: five-year follow-up of a psychosocial intervention. Br J Psychiatry. 2001;179:53-58.
90. Gleeson JF, Cotton SM, Alvarez-Jimenez M, et al. A randomized controlled trial of relapse prevention therapy for first-episode psychosis patients. J Clin Psychiatry. 2009;70:477-486.
91. Addington D, Addington J. First-episode psychosis. In: Mueser KT, Jeste DV, editors. Clinical handbook of schizophrenia. New York (NY): Guildford Press; 2008. p 367-379.
92. Birchwood M. Early intervention and sustaining the management of vulnerability. Aust N Z J Psychiatry. 2000;34:S181-S184.
93. Bertelsen M, Jeppesen P, Petersen L, et al. Five-year follow-up of a randomized multicenter trial of intensive early intervention vs standard treatment for patients with a first episode of psychotic illness: the OPUS trial. Arch Gen Psychiatry. 2008;65:762-771.
94. Craig TK, Garety P, Power P, et al. The Lambeth Early Onset (LEO) Team: randomised controlled trial of the effectiveness of specialised care for early psychosis. BMJ. 2004;329:1067.
95. Power P, Iacoponi E, Reynolds N, et al. The Lambeth Early Onset Crisis Assessment Team Study: general practitioner education and access to an early detection team in first-episode psychosis. Br J Psychiatry. 2007;51:s133-s139.
96. McGorry PD, Killackey E, Yung A. Early intervention in psychosis: concepts, evidence and future directions. World Psychiatry. 2008;7:148-156.
97. Angst J, Gamma A, Benazzi F, et al. Toward a re-definition of subthreshold bipolarity: epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania. J Affect Disord. 2003;73:133-146.
98. Correll CU, Penzner JB, Frederickson AM, et al. Differentiation in the preonset phases of schizophrenia and mood disorders: evidence in support of a bipolar mania prodrome. Schizophr Bull. 2007;33:703-714.
99. Duffy A, Alda M, Hajek T, et al. Early stages in the development of bipolar disorder. J Affect Disord. 2010;121(1-2):127-135.
100. Egeland JA, Hostetter AM, Pauls DL, et al. Prodromal symptoms before onset of manic-depressive disorder suggested by first hospital admission histories. J Am Acad Child Adolesc Psychiatry. 2000;39:1245-1252.
101. Kessing LV, Hansen MG, Andersen PK. Course of illness in depressive and bipolar disorders. Naturalistic study, 1994-1999. Br J Psychiatry. 2004;185:372-327.
102. Lewinsohn PM, Seeley JR, Klein DN. Bipolar disorders during adolescence. Acta Psychiatr Scand Suppl. 2003;(418):47-50.
103. Thompson KN, Conus PO, Ward JL, et al. The initial prodrome to bipolar affective disorder: prospective case studies. J Affect Disord. 2003;77:79-85.
104. Yung AR, McGorry PD. The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr Bull. 1996;22:353-370.
105. Hafner H, Maurer K, Trendler G, et al. The early course of schizophrenia and depression. Eur Arch Psychiatry Clin Neurosci. 2005;255:167-173.
106. Fava G, Tossani E. Prodromal stage of major depression. Early Interv Psychiatry. 2007;1:9-18.
107. Clarke GN, Hornbrook M, Lynch F, et al. A randomized trial of a group cognitive intervention for preventing depression in adolescent offspring of depressed parents. Arch Gen Psychiatry. 2001;58:1127-1134.
108. Hetrick SE, Parker AG, Hickie IB, et al. Early identification and intervention in depressive disorders: towards a clinical staging model. Psychother Psychosom. 2008;77:263-270.
109. Jaycox LH, Reivich KJ, Gillham J, et al. Prevention of depressive symptoms in school children. Behav Res Ther. 1994;32:801-816.
110. Stice E, Rohde P, Seeley JR, et al. Brief cognitive-behavioral depression prevention program for high-risk adolescents outperforms two alternative interventions: a randomized efficacy trial. J Consult Clin Psychol. 2008;76:595-606.
111. Garber J, Clarke GN, Weersing VR, et al. Prevention of depression in at-risk adolescents: a randomized controlled trial. JAMA. 2009;301:2215-2224.
112. Kuhn T. The structure of scientific revolutions. Chicago (IL): University of Chicago Press; 1962.